Invisible Illness Awareness Week 2016: Our Voices Need to Be Heard
Never heard of Invisible Illness Awareness Week? You're not alone. Jody Smith sheds a little light to make it more visible
Discuss the article on the Forums.

HEB (maker of Ampligen) paradoxically rated among favorite small cap stocks

Discussion in 'General ME/CFS News' started by WillowJ, Jul 11, 2011.

  1. WillowJ

    WillowJ คภภเє ɠรค๓թєl

    Messages:
    3,763
    Likes:
    4,831
    WA, USA
    the article says this is perplexing, "suspicious," and perhaps based on "hope," since there is no new news:
    http://www.smallcapnetwork.com/Real...CBAI-HEB/s/via/10/article/view/p/mid/3/id/18/

    I wonder if it has to do with investors reading the MLV abstracts from the International Human Retrovirus conference and realizing that retroviral causation could actually be a factor?

    I don't doubt that ampligen can help some deserving patients who need options, but I wonder if HEB can pull off readying a medication. More investors could help!

    Odd that the article says ampligen is for "chronic fatigue syndrome (CFS)", when Hemispherx says it's for important neuro-immune diseases. The article could at least use ME/CFS and spell out Myalgic Encephalomyelitis even if it didn't want to use space explaining what disease this is.
     

See more popular forum discussions.

Share This Page